MURRIETA, CA--(Marketwire - March 04, 2008) - CLX Investment Company, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that the Board of Directors has met and determined that a change in the name of the company is warranted. The Board expects to initiate the process of gaining majority shareholder approval for the name change at the soonest practicable date.
